Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma [2]
Journal
Oncologist
Journal Volume
11
Journal Issue
1
Pages
87-88
Date Issued
2006
Author(s)
SDGs
Other Subjects
allopurinol; alpha fetoprotein; creatinine; diuretic agent; glucose; insulin; lactate dehydrogenase; thalidomide; abdominal distension; abdominal pain; abnormally high substrate concentration in blood; adult; advanced cancer; alkalinization; cancer recurrence; cancer size; case report; chemoembolization; creatinine blood level; emergency ward; fatality; hemodialysis; human; hypercalcemia; hyperphosphatemia; hyperuricemia; jaundice; kidney dysfunction; kidney function; lactate dehydrogenase blood level; letter; liver cell carcinoma; low drug dose; male; metabolic acidosis; monotherapy; nephrotoxicity; priority journal; protein blood level; treatment response; tumor lysis syndrome; Angiogenesis Inhibitors; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Thalidomide; Tumor Lysis Syndrome
Type
letter